A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)

BACKGROUND: Clostridium difficile is the most common cause of hospital-acquired infections, responsible for >450000 infections annually in the USA. Probiotics provide a promising, well-tolerated adjunct therapy to standard C. difficile infection (CDI) treatment regimens, but there is a paucity of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Antimicrob Chemother
Autores principales: Barker, Anna K, Duster, Megan, Valentine, Susan, Hess, Timothy, Archbald-Pannone, Laurie, Guerrant, Richard, Safdar, Nasia
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2017
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890711/
https://ncbi.nlm.nih.gov/pubmed/28961980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkx254
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares